SubmissiontotheReviewofFundingArrangementsfor.docVIP

Submission to the Review of Funding Arrangements for Chemotherapy Services 29 July 2013 Contact for further information Richard Royle, Executive Director UntingCare Health Email: Richard.Royle@.au  Contents 1. Executive Summary ........................................................................................... 3 2. About UnitingCare Health................................................................................... 4 3. Model of Care for the provision of chemotherapy infusions at The Wesley Hospital ( from the clinical decision to order an infusion to follow up after the course or cycle has been completed).................................................................................... 4 4. Professional and administrative practices for the provision of chemotherapy and the business model that supports them: .................................................................... 6 4.1 Third party compounder business model ........................................................ 6 4.2 Dispensing and script management services .................................................. 7 4.3 Clinical pharmacy services ........................................................................... 10 5 Changes to the provision of chemotherapy medicine infusion services over recent years and there impact on consumer access to servicesError! Bookmark not defined. 6 Other Matters Pertinent to funding for chemotherapy infusion preparation ....... 13  1. Executive Summary Modern complex cancer therapies illustrate the progress made in recent years against advanced cancers that are resistant to traditional therapies. New targeted and immunotherapy drugs are emerging as viable strategies for halting the progression of these difficult diseases. Complex therapies demand multicomponent chemotherapy protocols incorporating chemotherapy agents (parenteral and/or oral), support